SUMMARY A new form of congenital myasthenia is described. An infant whose foetal movements during pregnancy had been weak presented at birth with muscle weakness and multiple contractures of the lower limbs. The clinical course was characterised by myasthenic crises during febrile illnesses. Neurophysiological studies demonstrated a decremental response at 2-3 HZ stimulation; this effect was reversed by edrophonium iv. At the age of eight months, a biopsy from the soleus muscle showed a predominance of type I fibres and variation in fibre diameters was slightly increased. Ultrastructural studies of the motor endplates revealed a marked reduction of postsynaptic membrane lengths with paucity of secondary clefts. Signs of focal degeneration were absent. The picture was reminiscent of foetal neuromuscular junctions. A developmental disorder of the postsynaptic membrane was considered to be the basic cause of the neuromuscular transmission defect.
Myasthenia is considered to be congenital if it presents before the age of two years in patients without circulating antibodies against acetylcholine receptors (AchR). Congenital myasthenia has been shown to be a heterogeneous condition. ' 2 Originally, two types were distinguished on the basis of clinical presentation:3 (1) familial infantile myasthenia in siblings with episodes of severe respiratory and feeding difficulties, lack of obvious extraocular muscle involvement and a tendency for spontaneous remission; (2) congenital myasthenia sensu stricti, manifest at birth or even during foetal life, usually involving extra-ocular muscles, together with persistent clinical symptoms.
Electrophysiological, ultrastructural. and his-tochemical studies carried out in the last five years, have shown that various defects of pre-and postsynaptic elements underlie true congenital myasthenia. To date, three different syndromes have been reported: (a) a deficiency of endplate acetylcholinesterase, small nerve terminals and reduced acetylcholine release;4 (b) putative defect of acetylcholine resynthesis or mobilisation;5 and (c) a putative defect of the acetylcholine-induced ion channel.6 In 1980, we described a patient with congenital myasthenia and arthrogryposis congenita. 7 The results of ultrastructural studies of motor endplates in this child are the subject of this paper. We shall present evidence to support the hypothesis that the transmission defect in this patient is due to a hitherto undescribed developmental disorder of the postsynaptic membrane.
Case history
The boy was born as the first child of young, healthy and non-consanguineous parents. Foetal movements during pregnancy had been weak. Delivery was spontaneous with cephalic presentation. Birth weight was 3500g. Postnatally, he showed mild respiratory distress with insufficient chest expansion, a weak cry, generalised muscle hypotonia and weakness, in particular witlh reference to sucking and swallowing. There were multiple contractures of the lower limbs. Gavage feeding was initially necessary. During the first months, the boy's mental development was normal, but there was a marked delay in motor milestones, together with progressive deformation, resulting in a funnel chest, scoliosis and subluxation of the hips.
An upper respiratory tract infection at the age of five months provoked bilateral ptosis, facial diplegia and tetraplegia. Myasthenia was diagnosed by means of a positive edrophonium test. Treatment was initiated with pyridostigmine bromide and this resulted in marked improvement of muscle strength. This treatment arrested progression of the orthopaedic abnormalities and facilitated motor development.
Immunological investigations showed that antibodies reactive to skeletal muscle and to the AchR were absent in the sera of mother and child.
Electromyography showed a 55% decrease in amplitude of action potentials during stimulation at the rate of 3 per second, and a progressive diminution of action potentials during stimulation at a rate of 30 per second. This effect was reversed by intravenous administration of 1 mg edrophonium. The percentage of the decremental response was calculated as the reduction in amplitude of the response to the fifth stimulus, compared to the amplitude of the response to the first stimulus.
Materials and methods

Patient material
At the age of eight months, a surgical correction of the talipes equinovarus was performed and a soleus muscle biopsy was taken for study of neuromuscular junctions.
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Endplate regions were located, as described by Engel,9 by cholinesterase staining according to the Koelle and Friedenwald method.'0 These parts were postfixed for two hours in 1% osmium tetroxide solution, dehydrated and embedded in epon, as in routine EM procedure. Motor endplates were identified in 1 ,tm sections stained with toluidine blue. Ultrathin sections were prepared from selected regions and contrasted with uranyl acetate followed by lead citrate and viewed in the electronmicroscope (Zeiss 109, Carl Zeiss, Oberkochen, FRG). Each neuromuscular junction, so observed, was photographed. A neuromuscular junction was defined as a nerve terminal with synaptic vesicles and the postsynaptic area of folds and clefts associated with it. When more than one neuromuscular junction occurred in an endplate section, each was analysed separately. A total of 56 neuromuscular junctions were studied in the patient, 61 neuromuscular junctions in control soleus muscles and 28 in the control intercostal muscle.
Morphometric analysis A computerised Image Analysis System (Videoplan, Kontron Messgerate, West Germany) was used for measuring the terminal axon area, the postsynaptic area and the preand postsynaptic membrane lengths of each neuromuscular junction. We defined the postsynaptic area as the sarcoplasm between the postsynaptic membrane and the contractile elements. Synaptic vesicle diameter and synaptic cleft width were measured by hand with a measuring magnifier (Polaron, MM15, Watford, Hertfordshire, GB). The presynaptic cleft length was not measured separately, but was considered to be equal to the length of the presynaptic membrane.
Statistical analysis of the quantitative data was made by means of the non-parametric Mann-Whitney U test.
Results
Control material
Light microscopy Control soleus muscle specimens were obtained from two In cross sections, a number of disseminated small other 8 month-old infants with talipes equinovarus, in angular fibres were seen. Histograms were conwhom physical examination and routine histochemical structed (fig 1) according to fibre size and type, as investigations of muscles had shown no signs of neuromus-judged from the myosine ATPase reaction." Nearly cular disorders. These two controls, and the patient, had all the fibres were between 10 and 20 ,um in diamebeen subjected to primary synaptic cleft length did not differ from controls and its width was normal. The mean postsynaptic membrane length was about half that of the controls and when the ratio postsynaptic membrane/presynaptic membrane length was calculated per neuromuscular junction, the difference was striking (p < 0.001). As there was no apparent difference in the length of the primary clefts, the difference in postsynaptic membrane length could be attributed mainly to the diminished length of the secondary clefts.
In our patient, the average number of infoldings per 10 ,um was calculated to be 2-4, whereas in controls there were 17 infoldings per 10 gm length. The sevenfold reduction in the number of infoldings, together with the fact that there was only a two-tothreefold reduction in postsynaptic membrane length, implies that the secondary clefts are longer.
Discussion
The clinical picture included multiple contractures and variable muscle weakness from birth. Prior to treatment, there was no complete remission, and febrile illnesses exacerbated the muscle weakness.
Electro-physiological investigations, showing a decreased response on repetitive stimulationreversible by intravenous administration of edrophonium-were conclusive for the diagnosis of myasthenia. As no antibodies to acetyicholine receptor protein compatible with the diagnosis congenital myascould be detected in the sera of mother and child, a thenia. diagnosis of autoimmune myasthenia gravis could Light microscopy of the soleus muscle biopsy almost definitely be excluded. The negative family showed a slightly increased variability in diameter of history and the presence of ptosis at birth, were the muscle fibres. The A-H factors were greater than in the controls. We have no explanation for this finding. The normal fibre type distribution indicated that the neuromuscular transmission disorder had permitted a normal maturation as expressed in fibre type differentiation. The ultrastructural findings with regard to the postsynaptic membrane, were highly abnormal. In our case, this membrane had fewer infoldings than controls and the secondary clefts were not arranged perpendicularly but almost parallel to the postsynaptic membrane. In fact, the secondary clefts did not look like clefts at all, but were more tube-like and circular in cross sections.
In the three months prior to biopsy, our patient received anticholine-sterase medication. Experimental studies have shown that structural changes may be induced by anticholinesterase drugs. The ultra-structural findings in the present case differed completely, however, from the degenerative alterations due to longterm anticholinesterase therapy, and also from the changes in membrane-bound organelles after acute treatment with a low dose of neostigmine. '2 13 Postsynaptic ultrastructural defects have been reported in two other forms of congenital myasthenia: degenerative changes were described in the slow-channel syndrome,6 and focal degeneration and membraneous networks which communicate with the synaptic space, in the endplatecholinesterase deficiency syndrome.4 In our patient signs of degeneration, such as widening of the primary or secondary synaptic clefts, with focal cytoplasmic degeneration, are totally absent.
Reduction of the postsynaptic membrane length and alterations in the shape of the secondary clefts are common findings in auto-immune myasthenia, but these changes are associated with degeneration and regeneration.' 14 The neuromuscular junctions in our patient resemble human foetal endplates at 16-20 weeks gestation. At 16 weeks, the postsynaptic membrane begins to fold and a few clearly defined secondary clefts become apparent. At 20 weeks, the clefts become more numerous and deeper. '5 6 The clinical signs of decreased foetal movement and the presence of congenital contractures at birth are compatible with an early neuromuscular transmission disturbance, due to a defect in the development of the neuromuscular junction.
Factors 
